TCL Archive NCI To Voluntarily Spends $196 Million On Breast Cancer; Will Require Reallocation November 13, 1992
TCL Archive Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival April 27, 2012
TCL Archive NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests June 5, 1992
TCL Archive In Brief: AACR Grants Record Number Of Awards To Young Investigators; Kersey Leads ASBMT April 24, 1998
